Impact of EMT in stage IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab.

Villalobos, Matthias; Czapiewski, Piotr; Reinmuth, Niels; Fischer, Jürgen R; Andreas, Stefan; Kortsik, Cornelius; Serke, Monika; Wolf, Martin; Neuser, Petra; Reuss, Alexander; Schnabel, Philipp A; Thomas, Michael

Villalobos, Matthias; Czapiewski, Piotr; Reinmuth, Niels; Fischer, Jürgen R; Andreas, Stefan; Kortsik, Cornelius; Serke, Monika; Wolf, Martin; Neuser, Petra; Reuss, Alexander; Schnabel, Philipp A; Thomas, Michael.

Afiliación

Villalobos M; Department of Thoracic Oncology, University Hospital Heidelberg and Translational Lung Research Center Heidelberg, Member of The German Center for Lung Research, D-69126 Heidelberg, Germany.
Czapiewski P; Department of Pathology, Otto-Von-Guericke University Magdeburg, D-39120 Magdeburg, Germany.
Reinmuth N; Department of Pathomorphology, Medical University of Gdansk, PL-80-210 Gdansk, Poland.
Fischer JR; Department of Pneumology/Oncology, Asklepios Fachkliniken München-Gauting, D-82131 Gauting, Germany.
Andreas S; Department of Oncology, Lungenklinik Löwenstein, D-74245 Löwenstein, Germany.
Kortsik C; Department of Pneumology, Lungenfachklinik Immenhausen, D-34376 Immenhausen, Germany.
Serke M; Department of Cardiology and Pneumology, Universitätsmedizin Göttingen, D-37099 Göttingen, Germany.
Wolf M; Department of Pneumology, Katholisches Klinikum Mainz, D-55131 Mainz, Germany.
Neuser P; Department of Pneumology/Oncology, Lungenklinik Hemer, D-58656 Hemer, Germany.
Reuss A; Medical Clinic IV, Department of Hematology/Oncology, Klinikum Kassel, D-34112 Kassel, Germany.
Schnabel PA; Coordinating Center for Clinical Trials, University Marburg, D-35043 Marburg, Germany.
Thomas M; Coordinating Center for Clinical Trials, University Marburg, D-35043 Marburg, Germany.

Oncol Lett ; 17(6): 4891-4900, 2019 Jun.

Article en En | MEDLINE | ID: mdl-31186697

Palabras clave

E-cadherin; epithelial-mesenchymal transition; non-small cell lung cancer; prognostic biomarkers; vimentin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Oncol Lett Año: 2019 Tipo del documento: Article País de afiliación: Alemania